People with life-threatening illnesses may eventually see improved access to experimental drugs at an earlier stage of the federal approval process, thanks to a bill that passed the House today.
By a vote of 250-169, the House passed federal “Right to Try” legislation, pushed by the Arizona-based libertarian Goldwater Foundation. This bill allows patients with what the government classifies as a “life-threatening” illness or condition to get access to drugs that have completed the first stage of clinical trial but are not yet fully approved by the Food and Drug Administration.
Most states have such laws on the books, but the federal government itself has lagged behind them in giving citizens permission to try experimental medication sooner if they’re dying.
Read the rest at Reason.com.
Trump’s National Security Strategy Breaks with Hegemony—But Not with Militarism
The Trump administration’s National Security Strategy of the United States of America, published last week, presents itself as a decisive break from the bipartisan foreign policy consensus that has shaped Washington’s posture since the end of the Cold War. In some...
